1. Home
  2. BBIO vs INM Comparison

BBIO vs INM Comparison

Compare BBIO & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • INM
  • Stock Information
  • Founded
  • BBIO 2015
  • INM 1981
  • Country
  • BBIO United States
  • INM Canada
  • Employees
  • BBIO N/A
  • INM N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • INM Biotechnology: Pharmaceutical Preparations
  • Sector
  • BBIO Health Care
  • INM Health Care
  • Exchange
  • BBIO Nasdaq
  • INM Nasdaq
  • Market Cap
  • BBIO N/A
  • INM 3.2M
  • IPO Year
  • BBIO 2019
  • INM N/A
  • Fundamental
  • Price
  • BBIO $35.96
  • INM $2.98
  • Analyst Decision
  • BBIO Strong Buy
  • INM
  • Analyst Count
  • BBIO 12
  • INM 0
  • Target Price
  • BBIO $53.00
  • INM N/A
  • AVG Volume (30 Days)
  • BBIO 2.5M
  • INM 55.8K
  • Earning Date
  • BBIO 04-29-2025
  • INM 05-13-2025
  • Dividend Yield
  • BBIO N/A
  • INM N/A
  • EPS Growth
  • BBIO N/A
  • INM N/A
  • EPS
  • BBIO N/A
  • INM N/A
  • Revenue
  • BBIO $221,902,000.00
  • INM $4,832,013.00
  • Revenue This Year
  • BBIO $14.88
  • INM N/A
  • Revenue Next Year
  • BBIO $121.23
  • INM N/A
  • P/E Ratio
  • BBIO N/A
  • INM N/A
  • Revenue Growth
  • BBIO 2285.27
  • INM N/A
  • 52 Week Low
  • BBIO $21.62
  • INM $1.72
  • 52 Week High
  • BBIO $39.47
  • INM $15.70
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 58.85
  • INM 60.92
  • Support Level
  • BBIO $33.21
  • INM $2.56
  • Resistance Level
  • BBIO $36.11
  • INM $3.15
  • Average True Range (ATR)
  • BBIO 2.10
  • INM 0.28
  • MACD
  • BBIO 0.27
  • INM 0.09
  • Stochastic Oscillator
  • BBIO 98.07
  • INM 88.11

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Share on Social Networks: